Mixtard 30 HM
Human insulin premix 30/70 (30% regular + 70% NPH) · 100 IU/mL (30% regular + 70% isophane/NPH)
Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Human insulin premix 30/70 (30% regular + 70% NPH)
- Therapeutic area
- Endocrine & metabolic
- Drug class
- Antidiabetic medicines
- ATC
- A10AD
- Strength
- 100 IU/mL (30% regular + 70% isophane/NPH)
- Dosage form
- Suspension for subcutaneous injection (vial)
- Pack
- 1's
- Registration no.
- 010348
- Price record verified
- 2026-08-07
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Novo Nordisk Pharma (Pvt.) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 1,000.32, effective 1 Jul 2024.
Cite this price history
MedInfoBase. Mixtard 30 HM 100 IU/mL (30% regular + 70% isophane/NPH), 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/mixtard-30-hm-100-iu-ml-30-regular-70-isophane-nph-010348-1s-novo-nordisk-pharma-pvt-ltd/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,000.32 | 2024-07-01 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 010348Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
